Loading ...
Sorry, an error occurred while loading the content.

18 Months of Dual Therapy for Chronic Hepatitis C Decreases Relapse Rate and Suggests New Treatment Approach for Hard to Treat Patients with Cirrhosis, Genotype 1, and High Baseline Viral load

Expand Messages
  • claudine intexas
    NATAP - www.natap.org Highlights from the 36th Annual Meeting of the European Association for the Study of the Liver (EASL 2001) April 18-22, 2001 Prague,
    Message 1 of 1 , Mar 2, 2002
    • 0 Attachment
      NATAP - www.natap.org

      Highlights from the 36th Annual Meeting of the European Association
      for the Study of the Liver (EASL 2001)
      April 18-22, 2001
      Prague, Czech Republic

      By Harvey S. Bartnof, MD
      Staff Physician at AVERI, AIDS Virus Education and Research Institute
      in San Francisco, CA.

      Part 2

      18 Months of Dual Therapy for Chronic Hepatitis C Decreases Relapse
      Rate and Suggests New Treatment Approach for Hard to Treat Patients
      with Cirrhosis, Genotype 1, and High Baseline Viral load

      http://www.natap.org/2001/36theasl/part2easl042401.htm

      __________________________________________________
      Do You Yahoo!?
      Yahoo! Sports - sign up for Fantasy Baseball
      http://sports.yahoo.com
    Your message has been successfully submitted and would be delivered to recipients shortly.